FTC and seven states seek contempt order against Martin Shkreli for breaching lifetime pharma ban

Martin Shkreli is again under investigation by the Federal Trade Commission.

The FTC, together with seven states, filed a petition in a New York federal court asking that Shkreli be held in contempt for allegedly violating a court-ordered lifetime ban that bars him from participating in the pharmaceutical industry.

The request reflects renewed regulatory scrutiny of Shkreli following previous enforcement actions, but the article does not provide details on any upcoming court decision.